ArticleOphthalmology and therapy2020

Retrospective Chart Review on Real-World Use of Latanoprostene Bunod 0.024% in Treatment-Naïve Patients with Open-Angle Glaucoma.

Constance O Okeke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.